Keratins and the keratinocyte activation cycle

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 633-640

  Freedberg, Irwin M ^a   Tomic Canic, Marjana ^a,b   Komine, Mayumi ^c   Blumenberg, Miroslav ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 1; KERATIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ATOPIC DERMATITIS; CELL ACTIVATION; CELL DIFFERENTIATION; CELL TYPE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; KERATINOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; SKIN DISEASE; WOUND HEALING;

EID: 0035006210     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01327.x     Document Type: Review

References (171)

1. Akira S, Isshiki H, Sugita T, et al: A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 9:1897-1906, 1997
2. Alitalo K, Kuismanen E, Myllyla R, Kiistala U, Asko-Seljavaara S, Vaheri A: Extracellular matrix proteins of human epidermal keratinocytes and feeder 3T3 cells. J Cell Biol 94:497-505, 1982
3. Barker JN, Mitra RS, Griffiths CE, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 337:211-214, 1991
4. Basset-Seguin N, Demoly P, Moles JP, et al: Comparative analysis of cellular and tissular expression of c-fos in human keratinocytes: evidence of its role in cell differentiation. Oncogene 9:765-771, 1994
5. Baud V, Liu ZG, Bennett B, Suzuki N, Xia Y, Karin M: Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev 13:1297-1308, 1999
6. Bechtel MJ, Reinartz J, Rox JM, Inndorf S, Schaefer BM, Kramer MD: Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha [published erratum appears in Exp Cell Res 1996, August 25: 227:170]. Exp Cell Res 223:395-404, 1996
7. Beg AA, Finco TS, Nantermet PV, Baldwin A Jr: Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cellular Biol 13:3301-3310, 1993
8. Bernerd F, Magnaldo T, Freedberg IM, Blumenberg M: Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins. Gene Expression 3:187-199, 1993
9. Blanton RA, Kupper TS, McDougall JK, Dower S: Regulation of interleukin 1 and its receptor in human keratinocytes. Proc Natl Acad Sci USA 86:1273-1277, 1989
10. Blumenberg M: The molecular link between the immune system and the epidermis: disease-activated transcription factor in human skin. Chronica Dermatologica 4:193-205, 1994
11. Bochner BS, Charlesworth EN, Lichtenstein LM, Derse CP, Gillis S, Dinarello CA, Schleimer RP: Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 86:830-839, 1990
12. Brasier A, Ron D, Tate J, Habener J: A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated transactivation of the angiotensinogen gene acute-phase response element. EMBO J 9:3933-3944, 1990
13. Burgeson RE: Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J Invest Dermatol 101:252-255, 1993
14. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF6 is a signal transducer for interleukin-1. Nature 383:443-446, 1996
15. Cartwright JE, Whitley GS, Johnstone AP: The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp Cell Res 217:329-335, 1995
16. Chan LS, Hammerberg C, Kang K, Sabb P, Tavakkol A, Cooper KD: Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism. J Invest Dermatol 99:315-322, 1992
17. Chen JD, Lapiere JC, Sauder DN, Peavey C, Woodley DT: Interleukin-1 alpha stimulates keratinocyte migration through an epidermal growth factor/ transforming growth factor-alpha-independent pathway. J Invest Dermatol 104:729-733, 1995
18. Chen P, Riley DJ, Chen Y, Lee WH: Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev 10:2794-2804, 1996
19. Choi Y, Fuchs E: TGF-β and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regulation 1:791-809, 1990
20. Chung JH, Youn SH, Koh WS, Eun HC, Cho KH, Park KC, Youn JI: Ultraviolet B irradiation-enhanced interleukin (IL) -6 production and RNA expression are mediated by IL-1 alpha in cultured human keratinocytes. J Invest Dermatol 106:715-720, 1996
21. Clark RA: Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 94:128S-134S, 1990
22. Coffey RJ Jr, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittlekow MR: Production and auto-induction of transforming growth factor-α in human keratinocytes. Nature 328:817-820, 1987
23. Corsini E, Primavera A, Marinovich M, Galli CL: Selective induction of cell-associated interleukin-1alpha in murine keratinocytes by chemical allergens. Toxicology 129:193-200, 1998
24. Debets R, Hegmans JP, Croughs P, Troost RJ, Prins JB, Benner R, Prens EP: The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 158:2955-2963, 1997
25. Dérijard B, Hibi M, Wu IH, et al: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037, 1994
26. Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424, 1997
27. Edwards DR, Murphy G, Reynolds J, Whitham SE, Docherty AJP, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 6:1899-1904, 1987
28. Eller MS, Yaar M, Ostrom K, Harkness DD, Gilchrest BA: A role for interleukin-1 in epidermal differentiation: regulation by expression of functional versus decoy receptors. J Cell Sci 108:2741-2746, 1995
29. Eron LJ, Toy C, Salsitz B, Scheer RR, Wood DL, Nadler PI: Therapy of genital herpes with topically applied Interferon. Antimicrobial Agents Chemotherapy 31:1137-1139, 1987
30. Fisher C, Byers MR, ladarola MJ, Powers EA: Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development 111:253-258, 1991
31. Fuchs E, Dowling J, Segre J, Lo SH, Yu QC: Integrators of epidermal growth and differentiation: distinct functions for beta 1 and beta 4 integrins. Curr Opin Genet Dev 7:672-682, 1997
32. Fujisawa H, Nakayama K, Nomura T, Kawachi Y, Otsuka F: Interleukin-1 and lipopolysaccharide enhance intercellular adhesion molecule-1 expression in cell lines of human squamous cell carcinoma. J Dermatol Sci 14:109-114, 1997a
33. Fujisawa H, Wang B, Kondo S, Shivji GM, Sauder DN: Costimulation with ultraviolet B and interleukin-1 alpha dramatically increase tumor necrosis factor-alpha production in human dermal fibroblasts. J Interferon Cytokine Res 17:307-313, 1997b
34. Gailit J, Welch MP, Clark RA: TGF-beta 1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J Invest Dermatol 103:221-226, 1994
35. Galcheva-Gargova Z, Derijard B, Wu IH, Davis RJ: An osmosensing signal transduction pathway in mammalian cells. Science 265:806-808, 1994
36. 1 null mouse phenotype. Proc Natl Acad Sci USA 90:9944-9948, 1993
37. Glick AB, Kulkarni AB, Tennenbaum T, et al: Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Natl Acad Sci USA 90:6076-6080, 1993
38. Godessart N, Vila L, Puig L, de Moragas JM: Interleukin-1 increases 15-hydroxyeicosatetraenoic acid production in human dermal fibroblasts. J Invest Dermatol 102:98-104, 1994
39. Grewe M, Gyufko K, Budnik A, Ruzicka T, Olaizola-Horn S, Berneburg M, Krutmann J: Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation. J Invest Dermatol 107:865-870, 1996
40. Griffiths CE, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
41. Griffiths TW, Griffiths CE, Voorhees JJ: Immunopathogenesis and immunotherapy of psoriasis. Dermatologic Clinics 13:739-749, 1995
42. Grinnell F: Wound repair, keratinocyte activation and integrin modulation. J Cell Sci 101:1-5, 1992
43. Guelstein VI, Tchypysheva TA, Ermilova VD, Litvinova LV, Troyanovsky SM, Bannikov GA: Monoclonal antibody mapping of keratins 8 and 17 and of vimentin in normal human mammary gland, benign tumors, dysplasias and breast cancer. Int J Cancer 42:147-153, 1988
44. Guo M, Kim LT, Akiyama SK, Gralnick HR, Yamada KM, Grinnell F: Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res 195:315-322, 1991
45. Gupta S, Campbell D, Derijard B, Davis RJ: Transcription actor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393, 1995
46. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, Davis RJ: Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15:2760-2770, 1996
47. Gyulai R, Hunyadi J, Kenderessy-Szabo A, Kemeny L, Dobozy A: Chemotaxis of freshly separated and cultured human keratinocytes. Clin Exp Dermatol 19:309-311, 1994
48. Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM: Interleukin 1 is present in normal human epidermis. J Immunol 136:3317-3323, 1986
49. Hill CS, Treisman R: Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell 80:199-211, 1995
50. Hu Y, Baud V, Delhase M, et al: Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284:316-320, 1999
51. Jhappan C, Geiser AG, Kordon EC, et al: Targeting expression of a transforming growth factor β 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12:1835-1845, 1993
52. Jiang CK, Magnaldo T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M: Epidermal growth factor and transforming growth factor alpha specifically induce the activation-and hyperproliferation-associated keratins 6 and 16. Proc Nat Acad Sci USA 90:6786-6790, 1993
53. Jiang CK, Flanagan S, Ohtsuki M, Shuai K, Freedberg IM, Blumenberg M: Disease-activated transcription factor: allergic reactions in human skin cause nuclear transcription of STAT-91 and induce synthesis of keratin K17, Mol Cell Biol 14:4759-4769, 1994
54. Jiang CK, Tomic-Canic M, Lucas DJ, Simon M, Blumenberg M: TGF beta promotes the basal phenotype of epidermal keratinocytes: transcriptional induction of K:5 and K:14 keratin genes. Growth Factors 12:87-97, 1995
55. de Jong EM, van Vlijmen IM, van Erp PE, Ramaekers FC, Troyanovski SM, van de Kerkhof PC: Keratin 17: a useful market in anti-psoriatic therapies. Arch Dermatol Res 283:480-482, 1991
56. Kaplan G, Witmer MD, Nath I, et al: Influence of delayed immune reactions on human epidermal keratinocytes. Proc Natl Acad Sci USA 83:3469-3473, 1986
57. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. Philos Trans R Soc London 351:127-134, 1996
58. Keski-Oja J, Koli K: Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-β1. J Invest Dermatol 99:193-200, 1992
59. Klampfer L, Lee TH, Hsu W, Vilcek J, Chen-Kiang S: NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1. Mol Cell Biol 14:6561-6569, 1994
60. Klement JF, Rice NR, Car BD, et al: IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol 16:2341-2349, 1996
61. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA: Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609-1614, 1990
62. Kolde G, Schulze-Osthoff K, Meyer H, Knop J: Immunohistological and immunoelectron microscopic identification of TNF alpha in normal human and murine epidermis. Arch Derm Res 284:154-158, 1992
63. Komine M, Freedberg IM, Blumenberg M: Regulation of epidermal expression of keratin K17 in inflammatory skin diseases. J Invest Dermatol 107:569-575, 1996
64. Komine M, Rao LS, Kaneko T, Tomic-Canic M, Tamaki K, Freedberg IM, Blumenberg M: Inflammatory vs proliferative processes in the epidermis: tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NFkB and C/EBPb. J Biol Chem 275:32077-32088, 2000
65. Kondo S, Sauder DN: Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Eur J Immunol 27:1713-1718, 1997
66. König A, Bruckner-Tuderman L: Transforming growth factor-β stimulates collagen VII expression by cutaneous cells in vitro. J Cell Biol 117:679-685, 1992
67. Kozlowska U, Blume-Peytavi U, Kodelja V, Sommer C, Goerdt S, Jablonska S, Orfanos CE: Vascular endothelial growth factor expression induced by proinflammatory cytokines (interleukin 1 alpha, beta) in cells of the human pilosebaceous unit. Dermatology 196:89-92, 1998
68. Kristensen M, Chu CQ, Eedy DJ, Feldmann M, Brennan FM, Breathnach SM: Localization of tumour necrosis factor-alpha (TNF-alpha) and its receptors in normal and psoriatic skin; epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 94:354-362, 1993
69. Krutmann J, Czech W, Parlow F, Trefzer U, Kapp A, Schopf E, Luger TA: Ultraviolet radiation effects on human keratinocyte ICAM-1 expression: UV-induced inhibition of cytokine-induced ICAM-1 mRNA expression is transient, differentially restored for IFN gamma versus TNF alpha, and followed by ICAM-1 induction via a TNF alpha-like pathway. J Invest Dermatol 98:923-928, 1992
70. Kubo M, Norris DA, Howell SE, Ryan SR, Clark RA: Human keratinocytes synthesize, secrete, and deposit fibronectin in the pericellular matrix. J Invest Dermatol 82:580-586, 1984
71. Kupper TS: The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 94:146S-150S, 1990a
72. Kupper TS: Role of epidermal cytokines. In: Oppenheim JJ, Shevach EM, eds. Immunophysiology. The Role of Cells and Cytokines in Immunity and Inflammation. London and New York: Oxford University Press, 1990b:pp 285-305
73. Kupper TS, Groves RW: The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 105:62S-66S, 1995
74. Kupper TS, Ballard DW, Chua AO, et al: Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. J Exp Med 164:2095-2100, 1986a
75. Kupper TS, Deitch EA, Baker CC, Wong WC: The human burn wound as a primary source of interleukin-1 activity. Surgery 100:409-415, 1986b
76. Kupper TS, Lee F, Birchall N, Clark S, Dower S: Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis. J Clin Invest 82:1787-92, 1988
77. Kutsch CL, Norris DA, Arend WP: Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol 101:79-85, 1993
78. La ON, Greene C: Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 63:650-657, 1998
79. Laiho M, Saksela O, Keski-Oja J: Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 262:17467-17474, 1987
80. Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K: Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor. Immunology 68:31-36, 1989
81. Lee RT, Briggs WH, Cheng GC, Rossiter HB, Libby P, Kupper T: Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. J Immunol 159:5084-5088, 1997
82. Lee WY, Butler AP, Locniskar MF, Fischer SM: Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 alpha mRNA in murine keratinocytes. J Biol Chem 269:17971-17980, 1994
83. Levy D, Darnell JE Jr: Interferon-dependent transcriptional activation: signal transduction without second messenger involvement? New Biologist 2:923-928, 1990
84. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM: Severe liver degeneration in mice lacking the IkappaB kinase 2 gene [see comments]. Science 284:321-325, 1999a
85. Li ZW, Chu W, Hu Y, et al: The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839-1845, 1999b
86. Ling L, Goeddel DV: T6BP, s TRAF6-interacting protein involved in IL-1 signaling. Proc Natl Acad Sci USA 97:9567-9572, 2000
87. Lisby S, Ralfkiaer E, Rothlein R, Vejlsgaard GL: Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation. Br J Dermatol 120:479-484, 1989
88. Liu ZG, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell 87:565-576, 1996
89. Lohman FP, Medema JK, Gibbs S, Ponec M, van de Putte P, Backendorf C: Expression of the SPRR cornification genes is differentially affected by carcinogenic transformation. Exp Cell Res 231:141-148, 1997
90. Lomaga MA, Yeh WC, Sarosi I, et al: TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 13:1015-1024, 1999
91. Lontz W, Sirsjo A, Liu W, Lindberg M, Rollman O, Torma H: Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Free Radic Biol Med 18:349-355, 1995
92. Lu B, Rothnagel JA, Longley MA, Tsai SY, Roop DR: Differentiation-specific expression of human keratin 1 is mediated by a composite AP-1/steroid hormone element. J Biol Chem 269:7443-7449, 1994
93. Lundqvist EN, Egelrud T: Biologically active, alternatively processed interleukin-1 beta in psoriatic scales. Eur J Immunol 27:2165-2171, 1997
94. Lyons JG, Birkedal-Hansen B, Pierson MC, Whitelock JM, Birkedal-Hansen H: Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem 268:19143-19151, 1993
95. Ma S, Rao L, Freedberg IM, Blumenberg M: Transcriptional control of K5, K6, K14, and K17 keratin genes by AP-1 and NF-kappaB family members. Gene Expr 6:361-370, 1997
96. Maas-Szabowski N, Fusenig NE: Interleukin-1-induced growth factor expression in postmitotic and resting fibroblasts. J Invest Dermatol 107:849-855, 1996
97. Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1. Nature 385:540-544, 1997
98. Marinkovich MP, Lunstrum GP, Keene DR, Burgeson RE: The dermal-epidermal junction of human skin contains a novel laminin variant. J Cell Biol 119:695-703, 1992
99. Matsumoto K, Hashimoto K, Hashiro M, Yoshimasa H, Yoshikawa K: Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-β. J Cell Physiol 145:95-101, 1990
100. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, Kishimoto T, Akira S: Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8, Proc Natl Acad Sci USA 90:10193-10197, 1993
101. Mauviel A, Heino J, Kahari VM, Hartmann DJ, Loyau G, Pujol JP, Vuorio E: Comparative effects of interleukin-1 and tumor necrosis factor-alpha on collagen production and corresponding procollagen mRNA levels in human dermal fibroblasts. J Invest Dermatol 96:243-249, 1991
102. Mauviel A, Chen YQ, Kahari VM, Ledo I, Wu M, Rudnicka L, Uitto J: Human recombinant interleukin-1 beta up-regulates elastin gene expression in dermal fibroblasts. Evidence for transcriptional regulation in vitro and in vivo. J Biol Chem 268:6520-6524, 1993
103. Mayrin EV, Habener JF: Transcription factors C/EBP alpha, C/EBP beta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110:238-246, 1998
104. Middleton MH, Norris DA: Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol 104:489-496, 1995
105. Mink S, Mutschler B, Weiskirchen R, Bister K, Klempnauer Kh: A novel function for Myc: inhibition of C/EBP-dependent gene activation. Proc Natl Acad Sci USA 93:6635-6640, 1996
106. Mischke D: The complexity of gene families involved in epithelial differentiation. Keratin genes and the epidermal differentiation complex. Subcell Biochem 31:71-104, 1998
107. Miyamoto S, Verma IM: Rel/NF-kappa B/I kappa B story. Adv Cancer Res 66:255-292, 1995
108. Mizutani H, Black R, Kupper TS: Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 87:1066-1071, 1991a
109. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS: Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821-825, 1991b
110. Moll R, Moll I, Franke WW: Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Derm Res 276:349-363, 1984
111. Murphy GM, Dowd PM, Hudspith BN, Brostoff J, Greaves MW: Local increase in interleukin-1-like activity following UVB irradiation of human skin in vivo. Photodermatol 6:268-274, 1989
112. Murphy JE, Robert C, Kupper TS: Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol 114:602-608, 2000
113. Muzio M, Ni J, Feng P, Dixit VM: IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612-1615, 1997
114. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S: Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 90:2207-2211, 1993
115. Nanney LB, Stoscheck CM, King LE Jr, Underwood RA, Holbrook KA: Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol 94:742-748, 1990
116. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M: Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275:200-203, 1997
117. Nickoloff BJ, Turka LA: Keratinocytes key immunocytes of the integument. Am J Pathol 143:325-331, 1993
118. Nickoloff BJ, Griffiths CE, Barker JN: The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease - 1990 update. J Invest Dermatol 94:151S-157S, 1990
119. Nickoloff BJ, Karabin GD, Barker JN, et al: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138:129-140, 1991
120. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, Matsumoto K: The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398:252-256, 1999
121. Nishio Y, Isshiki H, Kishimoto T, Akira S: A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 13:1854-1862, 1993
122. Nourshargh S, Larkin SW, Das A, Williams TJ: Interleukin-1-induced leukocyte extravasation across rat mesenteric microvessels is mediated by platelet-activating factor. Blood 85:2553-2558, 1995
123. Nylander-Lundqvist E, Egelrud T: Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol 77:203-206, 1997
124. Oh HS, Smart RC: Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 110:939-945, 1998
125. O'Keefe EJ, Woodley DT, Falk RJ, Gammon WR, Briggaman RA: Production of fibronectin by epithelium in a skin equivalent. J Invest Dermatol 88:634-639, 1987
126. Pankov R, Neznanov N, Umezawa A, Oshima RG: AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol Cell Biol 14:7744-7757, 1994
127. Pierce DF Jr, Johnson MD, Matsui Y, et al: Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β1. Genes Dev 7:2308-2317, 1993
128. Presland RB, Haydock PV, Fleckman P, Nirunsuksiri W, Dale BA: Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem 267:23772-23781, 1992
129. Rauschmayr T, Groves RW, Kupper TS: Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci USA 94:5814-5819, 1997
130. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M, Identification and characterization of an IkappaB kinase. Cell 90:373-383, 1997
131. Reiss M, Munoz-Antonia T, Cowan JM, Wilkins PC, Zhou Z-L, Vellucci VF: Resistance of human carcinoma cells to transforming growth factor β1 is a recessive trait. Proc Natl Acad Sci USA 90:6280-6284, 1993
132. Romero LI, Zhang DN, Herron GS, Karasek MA: Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells. J Cell Physiol 173:84-92, 1997
133. Rosette C, Karin M: Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol 128:1111-1119, 1995
134. Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692, 1994
135. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV: The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243-1252, 1995
136. van Ruissen F, van Erp PEJ, de Jongh GJ, Boezeman JBM, van de Kerkhof PCM, Schalkwijk J: Cell kinetic characterization of growth arrest in cultured human keratinocytes. J Cell Sci 107:2219-2228, 1994
137. Rutberg SE, Saez E, Glick A, Dlugosz AA, Spiegelman BM, Yuspa SH: Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 13:167-176, 1996
138. Ryynänen J, Sollberg S, Olsen DR, Uitto J: Transforming growth factor-B up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem Biophys Res Comm 180:673-680, 1991
139. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, Yuspa SH, Spiegelman BM: c-fos is required for malignant progression of skin tumors. Cell 82:721-732, 1995
140. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H: Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266:11436-11441, 1991
141. Santamaria Babi LF, Moser R, Perez Soler MT, Picker LJ, Blaser K, Hauser C: Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 154:1543-1550, 1995
142. Schindler C, Darnell J Jr: Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Ann Rev Biochem 64:621-651, 1995
143. Schweizer J: Murine epidermal keratins. In: Darmon M, Blumenberg M, eds. Molecular Biology of the Skin: the Keratinocyte, New York: Academic Press, 1993:pp 33-72
144. Seitz CS, Lin Q, Deng H, Khavari PA: Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc Natl Acad Sci USA 95:2307-2312, 1998
145. Sellheyer K, Bickenbach JR, Rothnagel JA, et al: Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237-5241, 1993
146. Shu HB, Takeuchi M, Goeddel DV: The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 93:13973-13978, 1996
147. Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
148. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M: Tumor necrosis factor (TNF) -mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 94:9792-9796, 1997
149. Stein B, Baldwin A Jr: Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 13:7191-7198, 1993
150. Stein B, Cogswell PC, Baldwin A Jr: Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol Cell Biol 13:3964-3974, 1993
151. Stosic-Grujicic S, Lukic ML: Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist (s). Immunology 75:293-298, 1992
152. Takeda K, Takeuchi O, Tsujimura T, et al: Limb and skin abnormalities in mice lacking IKKalpha. Science 284:313-316, 1999
153. Tanaka T, Akira S, Yoshida K, et al: Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-361, 1995
154. Tomic-Canic M, Komine M, Freedberg IM, Blumenberg M: Epidermal signal transduction and transcription factor activation in activated keratinocytes. J Dermatol Sci 17:167-181, 1998
155. Tosato G, Jones KD: Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. Blood 75:1305-1310, 1990
156. Trautwein C, Caelles C, van der Geer P, Hunter T, Karin M, Chojkier M: Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 364:544-547, 1993
157. Trefzer U, Brockhaus M, Loetscher H, Parlow F, Kapp A, Schopf E, Krutmann J: 55-kd tumor necrosis factor receptor is expressed by human keratinocytes and plays a pivotal role in regulation of human keratinocyte ICAM-1 expression. J Invest Dermatol 97:911-916, 1991
158. Troyanovsky SM, Leube RE, Franke WW: Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 59:127-137, 1992
159. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990
160. Umezawa A, Yamamoto H, Rhodes K, Klemsz MJ, Maki RA, Oshima RG: Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression. Mol Cell Biol 17:4885-4894, 1997
161. Vollberg TMSr, George MD, Jetten AM: Induction of extracellular matrix gene expression in normal human keratinocytes by transforming growth factor β is altered by cellular differentiation. Exp Cell Res 193:93-100, 1991
162. Wang G, Higgins PJ, Gannon M, Staiano-Coico L: Transforming growth factor-β1 acts cooperatively with sodium n-butyrate to induce differentiation of normal human keratinocytes. Exp Cell Res 198:27-30, 1992
163. Welter JF, Crish JF, Agarwal C, Eckert RL: Fos-related antigen (Fra-1), junB, and junD activate human involucrin promoter transcription by binding to proximal and distal AP1 sites to mediate phorbol ester effects on promoter activity. J Biol Chem 270:12614-12622, 1995
164. Wetzels RHW, Kuijpers HJ, Lane EB, et al: Basal cell-specific and hyperproliferation-related keratins in human breast cancer. Am J Pathol 138:751-763, 1991
165. Wikner NE, Persichitte KA, Baskin JB, Nielsen LD, Clark RAF: Transforming growth factor-β stimulates the expression of fibronectin by human keratinocytes. J Invest Dermatol 91:207-212, 1988
166. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1 alpha expression and release from a preformed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
167. Wyble CW, Hynes KL, Kuchibhotla J, Marcus BC, Hallahan D, Gewertz BL: TNF-alpha and IL-1 upregulate membrane-bound and soluble E-selectin through a common pathway. J Surg Res 73:107-112, 1997
168. Yu HS, Chang KL, Yu CL, Chen JW, Chen GS: Low-energy helium-neon laser irradiation stimulates interleukin-1 alpha and interleukin-8 release from cultured human keratinocytes. J Invest Dermatol 107:593-596, 1996
169. Zandi E, Chen Y, Karin M: Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 281:1360-1363, 1998
170. Zepter K, Haffner A, De Soohoo LF, et al: Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 159:6203-6208, 1997
171. Zhu S, Oh H, Shim M, Sterneck E, Johnson PF, Smart RC: C/EBPb modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and 10 expression. Mol Cell Biol 19:7181-7190, 1999